Highlights from Sting Demo Day – June 3, 2025
On June 3rd, Stockholm’s A‑House buzzed with excitement as 17 bold startups took the stage at Sting’s Demo Day.
ClearScanAI
Responsible coach:
Olof Berglund
Identify women that should go for supplemental breast cancer screening.
ClearScanAI identifies women who are at risk of having missed breast cancer during screening mammography and that would benefit from supplemental screening techniques such as MRI. By using its AI system in a clinical trial at Karolinska Hospital, it has been proven to stratify women at risk 4x better than using breast density alone.
.svg){kind=logo}